Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRON Stock Summary
Top 10 Correlated ETFs
CRON
CRON Financial details
Company Rating
Neutral
Market Cap
656.43M
Income
-155.34M
Revenue
87.02M
Book val./share
2.97
Cash/share
2.2
Dividend
-
Dividend %
-
Employees
447
Optionable
Yes
Shortable
Yes
Earnings
07 Aug 2023
P/E
-4.09
Forward P/E
-
PEG
0.67
P/S
7.54
P/B
0.56
P/C
0.76
P/FCF
-6.09
Quick Ratio
29.66
Current Ratio
31.45
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-0.41
EPS next Y
-
EPS next Q
-0.06
EPS this Y
-57.94%
EPS next Y
-
EPS next 5Y
26.12%
EPS last 5Y
40.6%
Revenue last 5Y
51.46%
Revenue Q/Q
-11.98%
EPS Q/Q
-75.9%
-
-
-
-
SMA20
-7.98%
SMA50
-9.9%
SMA100
-31.08%
Inst Own
10.08%
Inst Trans
0.69%
ROA
-13%
ROE
-13%
ROC
-0.1%
Gross Margin
9%
Oper. Margin
-125%
Profit Margin
-179%
Payout
-
Shs Outstand
393.07M
Shs Float
202.73M
-
-
-
-
Target Price
4
52W Range
1.66-3.616
52W High
-44%
52W Low
+68%
RSI
39.18
Rel Volume
0.66
Avg Volume
1.18M
Volume
784.56K
Perf Week
-4%
Perf Month
-8.7%
Perf Quarter
-40%
Perf Half Y
-41.87%
-
-
-
-
Beta
1.41916
-
-
Volatility
0.03%, 0.09%
Prev Close
-1.18%
Price
1.68
Change
-3.45%
CRON Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.07 | 0 | 0.13 | 0.2 | 0.24 | |
Net income per share | -0.08 | 0 | -0.21 | -1.07 | -0.45 | |
Operating cash flow per share | -0.04 | 0 | -0.41 | -0.41 | -0.24 | |
Free cash flow per share | -0.53 | 0 | -0.51 | -0.45 | -0.25 | |
Cash per share | 0.14 | 0 | 3.67 | 2.71 | 2.33 | |
Book value per share | 0.9 | 0 | 4.87 | 3.61 | 3.03 | |
Tangible book value per share | 0.85 | 0 | 4.15 | 3.55 | 2.95 | |
Share holders equity per share | 0.9 | 0 | 4.87 | 3.61 | 3.03 | |
Interest debt per share | 0.09 | 0 | 0.03 | 0.03 | 0.07 | |
Market cap | 2.44B | 0 | 3.11B | 1.85B | 1.3B | |
Enterprise value | 2.43B | -1.19B | 2.04B | 973.23M | 535.47M | |
P/E ratio | -172.92 | 0 | -41.69 | -4.66 | -7.68 | |
Price to sales ratio | 211.48 | 0 | 66.59 | 24.86 | 14.1 | |
POCF ratio | -340.99 | 0 | -21.84 | -12.05 | -14.57 | |
PFCF ratio | -26.67 | 0 | -17.49 | -11.16 | -13.79 | |
P/B Ratio | 15.7 | 0 | 1.82 | 1.38 | 1.13 | |
PTB ratio | 15.7 | 0 | 1.82 | 1.38 | 1.13 | |
EV to sales | 210.74 | -50.21 | 43.73 | 13.07 | 5.83 | |
Enterprise value over EBITDA | -209.19 | 0.85 | -12.76 | 43.87 | -9.05 | |
EV to operating cash flow | -339.79 | 9.17 | -14.34 | -6.34 | -6.02 | |
EV to free cash flow | -26.58 | 7.06 | -11.49 | -5.87 | -5.7 | |
Earnings yield | -0.01 | 0 | -0.02 | -0.21 | -0.13 | |
Free cash flow yield | -0.04 | 0 | -0.06 | -0.09 | -0.07 | |
Debt to equity | 0.1 | 0 | 0.01 | 0.01 | 0 | |
Debt to assets | 0.08 | 0 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | 0.74 | 0.85 | 6.67 | -39.54 | 12.85 | |
Current ratio | 1.43 | 4.72 | 6.63 | 19.86 | 14.1 | |
Interest coverage | -169.23 | 0 | -964.23 | 251.3 | -5.15 | |
Income quality | 0.51 | -0.11 | 1.89 | 0.39 | 0.53 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.38 | 2.57 | 2.05 | 1.43 | 0.94 | |
Research and developement to revenue | 0.15 | 0.51 | 0.44 | 0.31 | 0.15 | |
Intangibles to total assets | 0.05 | 0.14 | 0.13 | 0.01 | 0.02 | |
Capex to operating cash flow | 11.78 | 0.3 | 0.25 | 0.08 | 0.06 | |
Capex to revenue | -7.31 | -1.64 | -0.76 | -0.16 | -0.05 | |
Capex to depreciation | -45.72 | -9.95 | -5.02 | -0.8 | -0.38 | |
Stock based compensation to revenue | 0.27 | 0.49 | 0.33 | 0.14 | 0.16 | |
Graham number | 1.29 | 0 | 4.82 | 9.33 | 5.53 | |
ROIC | -0.1 | 1.13 | 0.67 | -0.02 | 0.44 | |
Return on tangible assets | -0.08 | 2.07 | -0.04 | -0.29 | -0.14 | |
Graham Net | 0 | 0 | 3.17 | 2.65 | 2.26 | |
Working capital | 14.37M | 1.24B | 1.17B | 1.03B | 892.04M | |
Tangible asset value | 145.82M | 1.46B | 1.46B | 1.32B | 1.11B | |
Net current asset value | 11.44M | 1.23B | 1.15B | 1.02B | 888.11M | |
Invested capital | 0.1 | 0 | 0.01 | 0.01 | 0 | |
Average receivables | 4.71M | 11.17M | 21.29M | 29.67M | 35.53M | |
Average payables | 8.83M | 23.35M | 38.7M | 26.66M | 11.19M | |
Average inventory | 12.41M | 26.61M | 41.02M | 38.4M | 35.18M | |
Days sales outstanding | 183.53 | 254.1 | 203.47 | 163.25 | 150 | |
Days payables outstanding | 1.28K | 309.63 | 211.81 | 44.52 | 50.97 | |
Days of inventory on hand | 1.7K | 333.68 | 221.37 | 130.18 | 171.5 | |
Receivables turnover | 1.99 | 1.44 | 1.79 | 2.24 | 2.43 | |
Payables turnover | 0.29 | 1.18 | 1.72 | 8.2 | 7.16 | |
Inventory turnover | 0.21 | 1.09 | 1.65 | 2.8 | 2.13 | |
ROE | -0.09 | 2.14 | -0.04 | -0.3 | -0.15 | |
Capex per share | -0.49 | 0 | -0.1 | -0.03 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | |
Net income per share | -0.09 | -0.05 | -0.1 | -0.21 | -0.05 | |
Operating cash flow per share | -0.09 | -0.05 | -0.04 | -0.06 | -0.13 | |
Free cash flow per share | -0.09 | -0.05 | -0.04 | -0.07 | -0.13 | |
Cash per share | 2.62 | 2.51 | 2.35 | 2.32 | 2.2 | |
Book value per share | 3.53 | 3.43 | 3.16 | 3.03 | 2.97 | |
Tangible book value per share | 3.47 | 3.35 | 3.09 | 2.94 | 2.89 | |
Share holders equity per share | 3.53 | 3.43 | 3.16 | 3.03 | 2.97 | |
Interest debt per share | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | |
Market cap | 1.82B | 1.36B | 1.46B | 1.3B | 998.5M | |
Enterprise value | 971.29M | 575.13M | 831.69M | 539.44M | 588.36M | |
P/E ratio | -13.96 | -16.67 | -9.88 | -4.12 | -12.96 | |
Price to sales ratio | 72.85 | 58.79 | 69.69 | 56.81 | 49.57 | |
POCF ratio | -53.77 | -78.46 | -108.93 | -53.35 | -20.94 | |
PFCF ratio | -52.64 | -70.67 | -97.14 | -51.72 | -20.59 | |
P/B Ratio | 1.38 | 1.05 | 1.22 | 1.14 | 0.88 | |
PTB ratio | 1.38 | 1.05 | 1.22 | 1.14 | 0.88 | |
EV to sales | 38.8 | 24.94 | 39.75 | 23.57 | 29.21 | |
Enterprise value over EBITDA | -44.87 | -25.49 | -47.94 | -1.21K | -58.11 | |
EV to operating cash flow | -28.64 | -33.28 | -62.14 | -22.13 | -12.34 | |
EV to free cash flow | -28.04 | -29.98 | -55.41 | -21.46 | -12.13 | |
Earnings yield | -0.02 | -0.02 | -0.03 | -0.06 | -0.02 | |
Free cash flow yield | -0.02 | -0.01 | -0.01 | -0.02 | -0.05 | |
Debt to equity | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Net debt to EBITDA | 39.37 | 34.6 | 36.11 | 1.71K | 40.51 | |
Current ratio | 26.42 | 26.18 | 25.37 | 14.1 | 31.45 | |
Interest coverage | -14.4 | -7.1 | -4.23 | -3.13 | -2.72 | |
Income quality | 1.04 | 0.85 | 0.36 | 0.31 | 2.48 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.04 | 0.85 | 1.02 | 0.84 | 0.74 | |
Research and developement to revenue | 0.16 | 0.19 | 0.12 | 0.11 | 0.1 | |
Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | 0.02 | 0.11 | 0.12 | 0.03 | 0.02 | |
Capex to revenue | -0.03 | -0.08 | -0.08 | -0.03 | -0.04 | |
Capex to depreciation | -0.26 | -0.45 | -0.47 | -0.29 | -0.33 | |
Stock based compensation to revenue | 0.15 | 0.11 | 0.2 | 0.2 | 0.13 | |
Graham number | 2.63 | 2.04 | 2.63 | 3.77 | 1.84 | |
ROIC | 0.08 | 0.1 | 0.83 | 0.15 | -0.06 | |
Return on tangible assets | -0.02 | -0.02 | -0.03 | -0.07 | -0.02 | |
Graham Net | 2.6 | 2.5 | 2.34 | 2.26 | 2.22 | |
Working capital | 1.02B | 986.86M | 925.34M | 892.04M | 887.01M | |
Tangible asset value | 1.3B | 1.26B | 1.17B | 1.11B | 1.1B | |
Net current asset value | 1.01B | 978.8M | 917.08M | 888.11M | 882.96M | |
Invested capital | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Average receivables | 34.32M | 32.25M | 30.37M | 34.67M | 32.62M | |
Average payables | 11.06M | 11.68M | 11.22M | 10.58M | 12M | |
Average inventory | 34.93M | 38.45M | 36.97M | 35.83M | 40.91M | |
Days sales outstanding | 127.08 | 113.81 | 135.81 | 148.53 | 122.75 | |
Days payables outstanding | 54.2 | 59.15 | 45.48 | 43.45 | 65.06 | |
Days of inventory on hand | 184.18 | 189.31 | 155.24 | 146.2 | 224.28 | |
Receivables turnover | 0.71 | 0.79 | 0.66 | 0.61 | 0.73 | |
Payables turnover | 1.66 | 1.52 | 1.98 | 2.07 | 1.38 | |
Inventory turnover | 0.49 | 0.48 | 0.58 | 0.62 | 0.4 | |
ROE | -0.02 | -0.02 | -0.03 | -0.07 | -0.02 | |
Capex per share | 0 | -0.01 | 0 | 0 | 0 |
CRON Frequently Asked Questions
What is Cronos Group Inc. stock symbol ?
Cronos Group Inc. is a CA stock , located in Toronto of On and trading under the symbol CRON
Is Cronos Group Inc. buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $4. The lowest prediction is $3.5 and the highest is $4.5
What is CRON stock prediction ?
What is Cronos Group Inc. stock quote today ?
Cronos Group Inc. stock price is $1.68 today.
Is Cronos Group Inc. stock public?
Yes, Cronos Group Inc. is a publicly traded company.